169 related articles for article (PubMed ID: 29531016)
21. Expression and function of the receptor protein tyrosine phosphatase zeta and its ligand pleiotrophin in human astrocytomas.
Ulbricht U; Brockmann MA; Aigner A; Eckerich C; Müller S; Fillbrandt R; Westphal M; Lamszus K
J Neuropathol Exp Neurol; 2003 Dec; 62(12):1265-75. PubMed ID: 14692702
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer.
Hu H; Li C; Cai S; Zhu C; Tian Y; Zheng J; Hu J; Chen C; Liu W
Hepatogastroenterology; 2014; 61(133):1478-82. PubMed ID: 25436328
[TBL] [Abstract][Full Text] [Related]
23. IDH1 status is significantly different between high-grade thalamic and superficial gliomas.
Zuo M; Li M; Chen N; Yu T; Kong B; Liang R; Wang X; Mao Q; Liu Y
Cancer Biomark; 2017 Aug; 20(2):183-189. PubMed ID: 28869450
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance and prognostic value of PAX3 expression in human glioma.
Chen J; Xia L; Wu X; Xu L; Nie D; Shi J; Xu X; Ni L; Ju S; Wu X; Zhu H; Shi W
J Mol Neurosci; 2012 May; 47(1):52-8. PubMed ID: 22231626
[TBL] [Abstract][Full Text] [Related]
25. Kinesin family member 14 is a candidate prognostic marker for outcome of glioma patients.
Wang Q; Wang L; Li D; Deng J; Zhao Z; He S; Zhang Y; Tu Y
Cancer Epidemiol; 2013 Feb; 37(1):79-84. PubMed ID: 22999822
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of interleukin-33 is associated with poor prognosis of patients with glioma.
Zhang J; Wang P; Ji W; Ding Y; Lu X
Int J Neurosci; 2017 Mar; 127(3):210-217. PubMed ID: 27050560
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of TELO2 decreases survival in human high-grade gliomas.
Feng SW; Chen Y; Tsai WC; Chiou HC; Wu ST; Huang LC; Lin C; Hsieh CC; Yang YJ; Hueng DY
Oncotarget; 2016 Jul; 7(29):46056-46066. PubMed ID: 27329594
[TBL] [Abstract][Full Text] [Related]
28. Expression and significance of urokinase-type plasminogen activator in human gliomas.
Zhang X; Bu X; Zhen H; Fei Z; Wu J; Gu J; Yi S; Wang Z
Chin Med J (Engl); 2000 Sep; 113(9):802-4. PubMed ID: 11776074
[TBL] [Abstract][Full Text] [Related]
29. Genetic Variants Related to Cell Cycle and Stability of Telomere in Patients with Glioma.
Calastri MCJ; Hattori G; Rodrigues NLTO; Gregorio ML; Brancati CIFO; Zanovelo EM; Ferraz Filho JRL; Neiva CM; Rodrigues Junior ACP; de Godoy MF; Lancellotti CLP; Tognola WA; Souza DRS
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2345-2351. PubMed ID: 31450905
[TBL] [Abstract][Full Text] [Related]
30. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
[TBL] [Abstract][Full Text] [Related]
31. Identification of P4HA1 as a prognostic biomarker for high-grade gliomas.
Hu WM; Zhang J; Sun SX; Xi SY; Chen ZJ; Jiang XB; Lin FH; Chen ZH; Chen YS; Wang J; Yang QY; Guo CC; Mou YG; Chen ZP; Zeng J; Sai K
Pathol Res Pract; 2017 Nov; 213(11):1365-1369. PubMed ID: 28964577
[TBL] [Abstract][Full Text] [Related]
32. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
33. Over-expression of wild-type p53-induced phosphatase 1 confers poor prognosis of patients with gliomas.
Liang C; Guo E; Lu S; Wang S; Kang C; Chang L; Liu L; Zhang G; Wu Z; Zhao Z; Ma S; Wang L; Jiao BH
Brain Res; 2012 Mar; 1444():65-75. PubMed ID: 22325093
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas.
Wu X; Wu F; Xu D; Zhang T
J Neurooncol; 2016 Apr; 127(2):221-32. PubMed ID: 26757925
[TBL] [Abstract][Full Text] [Related]
35. Predictive and prognostic value of TLR9 and NFKBIA gene expression as potential biomarkers for human glioma diagnosis.
Miyar A; Habibi I; Ebrahimi A; Mansourpour D; Mokarizadeh A; Rajabi A; Farshgar R; Eshaghzadeh M; Zamani-Ahmadmahmudi M; Nodushan SM
J Neurol Sci; 2016 Sep; 368():314-7. PubMed ID: 27538656
[TBL] [Abstract][Full Text] [Related]
36. [Expression and significance of ABCG2 in human malignant glioma].
Chu L; Huang Q; Zhai DZ; Zhu Q; Huo HM; Dong J; Qian ZY; Wang AD; Lan Q; Gao YL
Ai Zheng; 2007 Oct; 26(10):1090-4. PubMed ID: 17927879
[TBL] [Abstract][Full Text] [Related]
37. Stanniocalcin-1, a new biomarker of glioma progression, is associated with prognosis of patients.
Su J; Guo B; Zhang T; Wang K; Li X; Liang G
Tumour Biol; 2015 Aug; 36(8):6333-9. PubMed ID: 25783529
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of E-cadherin and N-cadherin expression in Gliomas.
Noh MG; Oh SJ; Ahn EJ; Kim YJ; Jung TY; Jung S; Kim KK; Lee JH; Lee KH; Moon KS
BMC Cancer; 2017 Aug; 17(1):583. PubMed ID: 28851312
[TBL] [Abstract][Full Text] [Related]
39. Deregulated expression of the clock genes in gliomas.
Chen Z; Liu P; Li C; Luo Y; Chen I; Liang W; Chen X; Feng Y; Xia H; Wang F
Technol Cancer Res Treat; 2013 Feb; 12(1):91-7. PubMed ID: 22905804
[TBL] [Abstract][Full Text] [Related]
40. Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma.
Chang C; Shi H; Wang C; Wang J; Geng N; Jiang X; Wang X
Neurosci Lett; 2012 Dec; 531(2):204-8. PubMed ID: 23103713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
